Marketing analysis of some groups antidiabetic medicines, presented at pharmaceutical market of Ukraine
Journal Title: Фармацевтичний журнал - Year 2017, Vol 2, Issue 2
Abstract
The scarcity of state resources, the social economic and demographic situation, the deterioration of health status of population require new state approaches of organizing medical and pharmaceutical provision for the population. The aim of the study is the drug supply for patients with type ІІ diabetes. Relevance of theme is determined by the prevalence of the disease, the development of complex concomitant diseases, complications, early disability and high mortality due to low-quality and untimely medical and pharmaceutical care for this category of patients. The object of marketing research was the drugs registered in Ukraine, which cost is the subject to reimbursement for outpatient treatment of patients with type ІІ diabetes by the conditions of March 2017. The search for the proposals of drugs under study on the website of Morion Company was also conducted to assess the real state of the pharmaceutical market on this issue. The main used methods are bibliographic, statistical, marketing, graphic and systematization. The Ukrainian pharmaceutical market of drugs with the cost, which is the subject to reimbursement for outpatient treatment of patients with type II diabetes, has been investigated, and found that Gliclazide and Metformin are registered on the territory of Ukraine in the form of 22 and 91 medicines, respectively. The part of domestic producers of Gliclazide and Metformin is 36% and 33%, respectively. It was revealed, that the assortment of drugs Gliclazide and Metformin, which are available in the pharmacy network, is 2 and 1.4 times less than registered in Ukraine, respectively. Gliclazide and Metformin tablets are offered by domestic and foreign manufacturers in a dosage of 30 mg, 60 mg, 80 mg and 500 mg, 800 mg, 1 000 mg, respectively.
Authors and Affiliations
I. V. Vyshnytska, V. V. Trokhymchuk
Keywords
Related Articles
- EP ID EP555994
- DOI 10.32352/0367-3057.2.17.01
- Views 68
- Downloads 0
Marketing analysis of modern market of drug with softening and protective action
The pharmaceutical market of dermatological preparations has up to 300 names (including all dosage forms), which is made more than 50 foreign companies, among them – 10 producers from Russia, Belarus, Estonia and 12 dome...
Synthesis, physical-chemical and biological properties of 8-aminoderivatives of 7-alkyl-3-methylxanthines
The search for new high-performance antimicrobial compounds remains one of the most important tasks of modern pharmaceutical chemistry, despite the wide range of modern natural, synthetic and semi-synthetic drugs for the...
Study of qualitative and quantitative composition of lipophilic compounds in the extract of pumpkin pulp (Cucurbita pepo L.)
The extracts of medicinal plants included into the composition of many drugs as active substances. Due to the presence in plants of different classes of biologically active substances with different pharmacological effec...
Problems of scientific substantiation of extemporaneous formulations technologies and ways of its solution. P a r t І. Retrospective view on the unification aspects of extemporaneous formulations
Extemporaneous formulations largely depend on practical experience and require constant analysis, the results of which should be reported to all the medical and pharmaceutical workers. The aim of the work is a retrospec...
Study of the base influence on the foaming properties gel shampoo with minoxidil
Alopecia causes a considerable psychological discomfort for the people and so it offers a great medical and social problem. Minoxidil has stayed practically the only medication with certainty recommendation for the recov...